GLP-1 weight-loss drugs will still be cheap with Medicare, but there's a catch

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
Becker's Hospital Review

CMS pauses weight-loss BALANCE model for Medicare

CMS pauses weight-loss BALANCE model for Medicare Part D after insufficient plan sponsor participation, while Medicaid pilot continues.

Medicare delays GLP-1 coverage plan; interim program extended

The Trump administration has extended a short-term program that offers Medicare coverage for weight loss drugs such as Novo’s (NVO) Wegovy and Lilly’s (LLY) Zepbound after leading health insurers ...

Dr. Oz announces a 50-state audit of Medicaid program oversight

NEW YORK (AP) — The Trump administration will require all 50 states to explain their plans to revalidate some of their ...

Medicare Delays Full Obesity-Drug Program Rollout After Insurers Push Back

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

Medicare Is Adding A Hemp and CBD Program—Here’s How It Works And Who Qualifies

In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
MedPage Today on MSN

Dr. Oz Announces 50-State Audit of Medicaid Program Oversight

Agency plans to ask states to "own" the problem of healthcare fraud ...